Many factors play into decision-making process when weighing agents.
Elizabeth Pan, MD
Advertisement
Articles by Elizabeth Pan, MD
Advertisement
Latest Updated Articles
GNRH agonists vs antagonists in prostate cancer: How to choosePublished: June 10th 2021 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
European Commission approves subcutaneous pembrolizumab
2
FDA grants 510(k) clearance to new edition of Focal One robotic HIFU
3
Kim Nguyen Chi, MD, highlights patient-reported outcome data from AMPLITUDE
4
Microultrasonography positioned as alternative to MRI for image-guided prostate biopsy
5
